does tirzepatide affect vision Blurred From Ozempic Go Away? [2026 Update] New Research Confirms Weight-Loss Drug

That is the advantage of the individualized, evidence-based care patients trust at Potere Health MD

Ideal Candidates for Direct Meds Adults with a BMI of 27+ with a weight-related health condition, or BMI of 30+ Patients who cannot afford or access brand-name GLP-1 medications through insurance People in states where Direct Meds USA operates who prefer a fully remote pharmacy experience Patients who have been screened and recommended for semaglutide or tirzepatide by a prior provider Individuals comfortable managing their care through a digital patient portal Who Should Avoid Direct Meds or Proceed with Caution Pregnant or breastfeeding women, GLP-1 medications are contraindicated Anyone under 18 years of age Patients with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN2) Patients with severe pancreatitis history or active pancreatic disease People in states not currently served by Direct Meds of Florida This qualification overview is for general guidance only

Additionally, both tirzepatide and semaglutide significantly decreased energy intake, increased satiety, reduced hunger, and lowered future meal consumption

The research team maintained complete independence from the funding source throughout the entire research process

Some people may respond well at 5 mg, while others may need a higher dose to reach their goals

The FDA prescribing information for tirzepatide (Mounjaro, Zepbound) does not list specific interactions with antibiotics